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7 Summary
The equine herpesvirus type 2 (EHV-2) interleukin-10 (IL-10) homologue:
Activity during acute and latent infection with special consideration on gene 
expression in vivo and in vitro
The aim of this work was to analyse the EHV-2 IL-10 homologue gene with special 
consideration on its gene expression in vitro and in vivo as well as its primary structure. 
Thereby it should be clarified if the EHV-2 IL-10 is related to a certain transcript class, if it is 
connected to a defined stage of infection and if the primary structure of EHV-2 IL-10 allows 
conclusions to its function.
The expression kinetics of the EHV-2 IL-10 gene were investigated by an EHV-2 IL-10 
specific seminested RT-PCR following an in vitro infection of a permanent equine dermal cell 
line (ED-cells) with the EHV-2 reference strain LK-4. EHV-2 IL-10 specific transcripts were 
already detected 6 hours post infection (p. i.), even before the transcripts of the immediate 
early EHV-2 ORF-50 and early late EHV-2 Glykoprotein B appeared. Furthermore, the 
implementation of protein synthesis inhibitors as well as inhibitors of viral DNA replication 
showed that the expression of EHV-2 IL-10 occurred independently from the protein 
synthesis and also from viral DNA replication. Therefore the in vitro expression of the EHV-2 
IL-10 was consistent with that of an immediate early herpes virus gene.
For the analysis of the EHV-2 IL-10 expression in vivo, blood samples of three naturally with 
EHV-2 infected horses were examined monthly over a period of one year. Parallel the EHV-2 
infection stage of the horses was determined. The results of serological analysis implied 
hints of an existing acute EHV-2 infection, but there was no evidence of productive virus 
replication in the peripheral blood mononuclear cells (PBMC) of all three horses either by 
RT-PCR for EHV-2 ORF-50 and gB expression as markers for virus replication or by plaque 
assay for the detection of infectious virus in destroyed cells. From the PBMC of two horses 
latent EHV-2 was isolated by cocultivation, whereas the implementation of 
12-O-tetradecanoylphorbol-13-acetate (TPA) had a positive effect on the reactivation of the 
latent virus. With the EHV-2 PCR positive PBMC of the third horse the cocultivation was 
always negative. Additionally Gardella gel analysis indicated that the DNA of latently infected 
equine PBMC contained integrated EHV-2 DNA.
In the latently infected PBMC of two horses EHV-2 IL-10 specific transcripts were detected, 
whereas no EHV-2 IL-10 transcripts could be found in the PBMC of the third horse. The 
expression in latently infected PBMC suggests that the EHV-2 IL-10 takes part in the latent 
EHV-2 infection. However the question about the possible implementation of EHV-2 IL-10 
transcripts as a diagnostic marker for the latent EHV-2 infection cannot be answered 
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conclusively. Possible EHV-2 IL-10 functions in latently infected equine PBMC and ways of 
further examinations of these results will be discussed.
Comparative studies of the EHV-2 IL-10 primary structure of 9 EHV-2 reference strains and 
field isolates revealed a high level of amino acid conservation of 96 % to 100 %. Moreover 
the EHV-2 IL-10 matches the equine IL-10 protein in 85 % of the amino acids. In addition 
phylogenetic analysis of EHV-2 IL-10 and equine IL-10 were conducted on basis of a 
developed phylogenetic tree. As a result both IL-10 proteins showed a high degree of 
homology, suggesting that the EHV-2 IL-10 was captured from the horse during evolution. An
amino acid alignment with EBV, parapoxvirus orf, human and ovine IL-10 was carried out to 
identify candidate functional domains of EHV-2 IL-10. As a result regions were detected, 
which posses immune stimulating functions in the cellular IL-10 protein, that had not been 
preserved in the EHV-2 IL-10 as well as the EBV IL-10. Possibly EHV-2 IL-10, like EBV 
IL-10, preserved only the immunosuppressive qualities of the host IL-10, whereby a 
therapeutical implementation of the EHV-2 IL-10 would be conceivable with 
immunopathological diseases of the horse.
In conclusion, the results of the current work show that the established EHV-2 IL-10 specific 
snRT-PCR is a sensitive and specific tool for the verification of EHV-2 IL-10 expression. This 
method presents an opportunity for further analysis of the role of the EHV-2 IL-10 in vivo. 
Indications for immunomodulatory effects and probably functional differences to the equine 
counterpart as observed by computer based sequence analysis, have to be verified by 
functional studies in adequate model systems.
